Genmab | Brutto Fortjeneste På Salg



Gross Profit On Sales Endring Dato
Agios Pharmaceuticals USD 9.47M 1.29M 2024-12
Almirall EUR 231.69M 73.09M 2024-06
Amarin USD 16.28M 26.49M 2024-09
Amgen USD 5.97B 781M 2024-12
argenx SE USD 665.76M 371.88M 2024-12
AstraZeneca USD 11.35B 819M 2025-03
Bayer EUR 6.01B 1.13B 2024-12
BioMarin Pharmaceutical USD 611.17M 53.89M 2024-12
Demant DKK 8.58B 4.32B 2024-12
Exelixis USD 546.79M 24.58M 2025-01
Fresenius Medical Care EUR 1.27B 124.43M 2024-12
Galapagos EUR 61.25M 98.68M 2025-03
Genmab DKK 6.1B 837M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
GN Store Nord DKK 2.67B 389M 2024-12
GRIFOLS EUR 766.49M 39.74M 2024-12
Hikma Pharmaceutical USD 756M 82M 2024-06
Insmed USD 78.29M 6.04M 2024-12
Lonza CHF 1.12B 276M 2024-06
Merck EUR 3.1B 45M 2024-12
Novartis USD 10.23B 294M 2024-12
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
UCB EUR 970M 788M 2024-06



Genmab Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.